News:
Oct. 03, 2025 – Radiant Biotherapeutics to Present Next-Generation Multabody™ Approach
for Cancer Immunotherapy at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Jul. 09, 2025 – Radiant Biotherapeutics Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer
Sept. 11, 2024 – Radiant Bio Closes $35 Million Series A Financing to Advance Therapeutic Pipeline with Its Proprietary Multabody™ Platform
Dec. 20, 2023 – Radiant to Assess Multi-Valent, Multi-Specific Multabodies as Potential Treatments for HIV
Investors:
